![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-8276bfde6a9f199e786c3c028d97634ee76d63c88161cb27779a77376066be39.jpg)
Intravesical Botulinum Toxin for Adults with Non-Neurogenic Bladder Conditions: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.